What does that mean? Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day. We'll keep all topic alert notifications available on your dashboard for 30 ...
Without insurance, a mammogram can cost less than $200 to more than $300. With insurance, out-of-pocket expenses vary based on your plan, type of imaging, and where the test is performed.
The hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2) patients had a crude LRR rate of 2.8% and a 3-year actuarial rate of 3.2%. The HER2+ patients had a crude LRR rate of 2.7% and a 3-year actuarial rate of 3.3%.Locoregional recurrence is...
patients have received a considerable proportion of the recommended chemotherapy cycles. However, sustained elevation of CA15-3 appears to be more frequent with poor prognostic groups of our cohort: those that were HER2 positive and had a high Ki67 index. The post-surgical CA15-3 at 3 months fo...
Trastuzumab is successfully used for the treatment of HER2-positive breast cancer. Because of its association with cardiotoxicity, LVEF is monitored by MUG
A tumor was considered negative for ER and PR if staining was present in <1% of tumor cells (at any intensity), with satisfactory positive and negative controls.19 Human epidermal growth factor receptor 2 (HER2) immunohistochemical testing was done against a control, with the membrane intensity ...
Trastuzumab in combi- nation with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–697. 24. Ohtsu A, Shah MA, van Cutsem E, et...
Does the Choice of First-Line Chemotherapy Influence the Outcome of ER+HER2: Metastatic Breast Cancer?Clonal expansion of large granular lymphocyte(LGL) have been classified into T-LGL and NK-LGL leukemia. T-LGL leukemia cells have a CD3+ phenotype and show clonal T-cell receptor(TCR) gene ...
Objective. To investigate the effect of neoadjuvant chemotherapy in HER2 negative luminal B breast cancer. Patients and methods.Patients between January 2016 and December 2021 were retrospectively evaluated. Results. A total of 128 patients were included in the study. Patients with pathological complete...
We conducted multi-level analyses on patients with ER-positive HER2-negative invasive disease (N=2973) to examine oncologists' influence on variation in RS testing and chemotherapy receipt, using patient and oncologist survey responses merged to SEER data. RESULTS: Half of patients (52.8%) ...